Biederstädt, Alexander;Rezvani, Katayoun
How I treat high-risk acute myeloid leukemia using preemptive adoptive cellular immunotherapy.
Blood
2023
141
1
22-38

Illert, A L;Stenzinger, A;Bitzer, M;Horak, P;Gaidzik, V I;Möller, Y;Beha, J;Öner, Ö;Schmitt, F;Laßmann, S;Ossowski, S;Schaaf, C P;Hallek, M;Brümmendorf, T H;Albers, P;Fehm, T;Brossart, P;Glimm, H;Schadendorf, D;Bleckmann, A;Brandts, C H;Esposito, I;Mack, E;Peters, C;Bokemeyer, C;Fröhling, S;Kindler, T;Algül, H;Heinemann, V;Döhner, H;Bargou, R;Ellenrieder, V;Hillemanns, P;Lordick, F;Hochhaus, A;Beckmann, M W;Pukrop, T;Trepel, M;Sundmacher, L;Wesselmann, S;Nettekoven, G;Kohlhuber, F;Heinze, O;Budczies, J;Werner, M;Nikolaou, K;Beer, A J;Tabatabai, G;Weichert, W;Keilholz, U;Boerries, M;Kohlbacher, O;Duyster, J;Thimme, R;Seufferlein, T;Schirmacher, P;Malek, N P
The German Network for Personalized Medicine to enhance patient care and translational research.
Nat Med
2023
29
6
1298-1301

van der Garde, M.;Thomas, M.;Riviere, J.;Metzeler, K. H.;Basserman, F.;Hecker, J. S.;Marr, C.;Goetze, K. S.
MULTIOMIC ANALYSIS OF CHIP BONE MARROW HEMATOPOIETIC STEM/PROGENITOR CELLS REVEALS A POTENTIAL EARLY STAGE OF MALIGNANCY
Ann Hematol
2023
102 Suppl 1
SUPPL 1
S18-S19

Joensuu, Heikki;Wardelmann, Eva;Eriksson, Mikael;Reichardt, Annette;Hall, Kirsten Sundby;Schütte, Jochen;Cameron, Silke;Hohenberger, Peter;Sihto, Harri;Jost, Philipp J;Lindner, Lars H;Bauer, Sebastian;Nilsson, Bengt;Kallio, Raija;Pesonen, Tommi;Reichardt, Peter
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.
Clin Cancer Res
2023
29
17
3313-3319

Schulze, T.;Spallek, R.;Oellinger, R.;Zecha, J.;Rad, R.;Kuester, B.;Bassermann, F.
Identification and characterization of KLHL14 as a novel tumor suppressor in in B cell malignancies
Oncology Research and Treatment
2023
46 Suppl 5
236-236

Schwarz, A.;Goeldel, S.;Eismann, T.;Tiefgraber, M.;Urban, M.;Herhaus, P.;Bassermann, F.;Verbeek, M.;Orberg, Thiele E.
Comparison of the microbiome in saliva and stool in allogeneic stem cell transplanted patients: do salivary signatures predict changes in the gut?
Oncology Research and Treatment
2023
46 Suppl 5
263-264

Bug, Gesine;Labopin, Myriam;Niittyvuopio, Riitta;Stelljes, Matthias;Reinhardt, Hans Christian;Hilgendorf, Inken;Kröger, Nicolaus;Kaare, Ain;Bethge, Wolfgang;Schäfer-Eckart, Kerstin;Verbeek, Mareike;Mielke, Stephan;Carlson, Kristina;Bazarbachi, Ali;Spyridonidis, Alexandros;Savani, Bipin N;Nagler, Arnon;Mohty, Mohamad
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
2023
58
6
710-716

Fuechsl, F.;Untch, J.;Kavaka, V.;Jarosch, S.;Vogelsang, C.;Kraetzig, N. de Andrade;Gosmann, D.;Rad, R.;Busch, D.;Beltran, E.;Braeunlein, E.;Krackhardt, A.
PROFILING NEOANTIGEN-SPECIFIC T CELL RECEPTOR ACTIVATION: MODERATE STIMULATION PATTERNS LINKED TO INCREASED T CELL RESILIENCE
Hum Gene Ther
2023
34
21-22
A17-A17

Zuleger, G.;Lutzenberger, S.;Lee, C. -Y.;Kraetzig, N. De Andrade;Tretter, C.;Hiltensperger, M.;Rad, R.;Braeunlein, E.;Krackhardt, A.
MASS SPECTROMETRY-BASED IMMUNOPEPTIDOMICS APPROACH REVEALS IMMUNOGENICITY OF A POTENTIAL NEOANTIGEN IN THE MULTIPLE MYELOMA CELL LINE JJN3
Hum Gene Ther
2023
34
21-22
A44-A45

Pachzelt, L.;Riviere, J.;Nolde, M.;Metzeler, K. H.;Haferlach, T.;Bassermann, F.;Goetze, K. S.;Hecker, J. S.
CHIP AND EVOLUTION TO HEMATOPOIETIC MALIGNANCIES: INSIGHTS FROM A SPECIALIZED CLINIC
Ann Hematol
2023
102 Suppl 1
SUPPL 1
S34-S34